IR 2026 Q3 Financial Summary for Fiscal Year Ending December 2026
Mizho Media Co., Ltd. has released the financial summary for the third quarter of fiscal year ending December 2026. Details can be confirmed via the PDF link.
Mizuho Medical Co., Ltd.
株式会社ミズホメディーMIZUHO MEDY Co.,Ltd.Alias
§01
Basic information
- Head office
- 5-4 Fujiki-cho, Tosu City, Saga Prefecture 841-0048, Japan
- Chief executive
- Fuminaro Karakawa
- Capital
- 464,540,000 (4 100 million)
- Employees (non-consolidated)
- 240 people
- Employees (consolidated)
- 242 people
- Start date
- 1977-11-02
- End date
§02
Websites
§03
Business
Diagnostic drug businessHealthcare business
§04
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| 株式会社AMBiS |
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
Drag to move · click to open
§06
History
November 1977: Established as a clinical reagent sales company in Hakata-ku, Fukuoka City (Capital: 5 million yen)
Established as a clinical reagent sales company in Hakata-ku, Fukuoka City (Capital: 5 million yen)
September 1981: Moved headquarters to Tosu City, Saga Prefecture (new company building completed): Changed business purpose to manufacturing and sales of in vitro diagnostic pharmaceuticals
Relocated headquarters to Tosu City, Saga Prefecture (new building completed): Changed business purpose to manufacturing and sales of in vitro diagnostic medical devices
March 1983: Company name changed to Mizuho Medical Co., Ltd.
Company name changed to Mizuhome Medical Inc.
August 1983: Opened Tokyo Sales Office
Established Tokyo sales office
October 1983: Opened Osaka Sales Office
Established Osaka sales office
May 1984: Started overseas exports
Started overseas exports
July 1986: Opened Nagoya Sales Office
Established Nagoya sales office
December 1988: Capital increased to 95 million yen
Capital increased to 95 million yen
September 1989: Moved headquarters (new factory completed in Tosu City, Saga Prefecture)
Relocated headquarters (new factory completed in Tosu City, Saga Prefecture)
December 1990: Capital increased to 329.75 million yen
Capital increased to 329.75 million yen
March 1995: Expanded headquarters factory (Tosu City, Saga Prefecture)
Expanded headquarters factory (Tosu City, Saga Prefecture)
October 1997: Established OTC Business Division (for pharmacies and drugstores)
Established OTC business division (for pharmacies and drugstores)
October 2004: Started sales of products for clinicians (influenza test kits)
Start selling products for clinics (Influenza test kits)
March 2005: Expanded headquarters warehouse (Tosu City, Saga Prefecture)
Expansion of headquarters warehouse (Tosu City, Saga Prefecture)
September 2008: Obtained ISO13485 certification
Obtained ISO13485 certification
September 2010: Expanded headquarters factory (Tosu City, Saga Prefecture)
Expansion of headquarters factory (Tosu City, Saga Prefecture)
September 2012: Expanded headquarters inspection and research building (Tosu City, Saga Prefecture)
Expansion of headquarters inspection and research building (Tosu City, Saga Prefecture)
December 2015: Listed on the JASDAQ Market of the Tokyo Stock Exchange; Capital increased to 464.54 million yen (current)
Listed on the JASDAQ market of the Tokyo Stock Exchange: Capital increased to 464.54 million yen (current)
February 2018: Approval for domestic manufacturing and sale of respiratory infection gene test kit (Smart Gene Myco)
Obtained approval for domestic manufacturing and sales of respiratory infectious disease gene test kit (Smart Gene Myco)
October 2018: Launch of fully automated gene analysis system (Smart Gene) and respiratory infection gene test kit (Smart Gene Myco)
Start sales of fully automated gene analysis device (Smart Gene) and respiratory infectious disease gene test kit (Smart Gene Myco)
November 2018: Changed market to Tokyo Stock Exchange Second Section
Changed market to the Second Section of the Tokyo Stock Exchange
May 2019: Completion of Kurume Factory and Gene Research Institute (Kurume City, Fukuoka Prefecture)
Completion of Kurume Factory and Gene Research Institute (Kurume City, Fukuoka Prefecture)
September 2019: Start of operation at Kurume Factory and Gene Research Institute (Kurume City, Fukuoka Prefecture)
Start operation of Kurume Factory and Gene Research Institute (Kurume City, Fukuoka Prefecture)
August 2020: Started selling COVID-19 gene test kit (Smart Gene COVID-19 detection reagent) as a research reagent covered by public medical insurance
Started selling COVID-19 gene test kit (Smart Gene COVID-19 detection reagent) as a research reagent covered by public medical insurance
April 2021: Replaced research reagent (Smart Gene COVID-19 detection reagent) with in vitro diagnostic medical device (Smart Gene SARS-CoV-2) with approval and licensing
Started selling Smart Gene SARS-CoV-2, which has obtained approval as an in vitro diagnostic medical device, replacing the research reagent (Smart Gene COVID-19 detection reagent) covered by public medical insurance
April 2022: Transitioned from Second Section to new market segment
Due to reorganization of the Tokyo Stock Exchange market segments, transitioned from the Second Section to the new market segment
§07
News
IR 2026 Q3 Financial Summary for Fiscal Year Ending December 2026
IR "TOPIX Next-tier" constituent selection has been published.
IR "TOPIX Next-tier" constituent selection has been published.
Nagoya Branch Closure Notice
We have posted the Nagoya Branch Closure Notice.
IR Announcement of New Product Release: Quick Chaser Auto RSV/hMPV
Mizuhome Media Co., Ltd. announced the release of the new product "Quick Chaser Auto RSV/hMPV" as an IR news item. Details are posted on the company's IR page, and a PDF link is provided.
Exhibition at the 58th Annual Meeting & Scientific Conference of the Japanese Pediatric Infectious Diseases Society
Mizuhome Corporation will exhibit at the 58th Annual Meeting & Scientific Conference of the Japanese Pediatric Infectious Diseases Society, held at Pacifico Yokohama North from October 24 to 25, 2026.
Mizuho Medy Launches Dedicated Page for New Smart Gene H. pylori S
Mizuho Medy Co., Ltd. launched a dedicated page for healthcare professionals about its new Smart Gene H. pylori S product. The page provides information to support the appropriate use of prescription medicines.
Co-hosted Seminar Announcement for the 53rd Japanese Pediatric Nutrition, Gastroenterology, and Hepatology Society Academic Conference
The co-hosted seminar of the 53rd Japanese Pediatric Nutrition, Gastroenterology, and Hepatology Society Academic Conference will be held on September 27, 2026, at the Awaji Yumebutai International Conference Center. The lecture will introduce primary prevention of Helicobacter pylori screening in middle school students, nationwide survey results, and patient voices.
Mizuho Medy to Exhibit at JACLaS EXPO 2026
Mizuho Medy will exhibit at JACLaS EXPO 2026 at Kobe International Exhibition Hall from October 8 to 10, 2026. The booth will be open from 9 a.m. to 5:30 p.m. on October 8 and 9, and from 9 a.m. to 2 p.m. on October 10. English-speaking staff will be available on October 8 and 9. Visitors are welcome to explore the products.
Mizuho Medy Updates FY2026 Q3 Earnings Announcement Date
Mizuho Medy Co., Ltd. has updated the announcement date for its third-quarter results for the fiscal year ending December 2026. The revised schedule is listed in the investor relations calendar on the company website.
IR Notice: Launch of New Smart Gene H. pylori S Product
Mizuho Medy Co., Ltd. announced the launch of its new Smart Gene H. pylori S product in an investor relations news release. See the PDF on the company’s official website for details.
§08
Public records
National Tax Agency basic information2300001006311
Source: National Tax Agency Corporate Number Publication Site, basic three items
- Trade name
- 株式会社ミズホメディー
- Trade name (kana)
- ミズホメディー
- Name in English
- Corporation type
- 301
- Address
- 〒841-0048 佐賀県鳥栖市藤木町５番地の４
- Postal code
- 8410048
- Prefecture code
- 41
- City code
- 203
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2015-10-05
- Update date
- 2018-04-12
- Change date
- 2015-10-28
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 11
- Correction type
- 1
- Trade name image ID
- Address image ID
- Sequence number
- 5377078
METI gBizINFO2300001006311
Source: gBizINFO (Ministry of Economy, Trade and Industry)
- Corporate number
- 2300001006311
- Trade name
- 株式会社ミズホメディー
- Trade name (kana)
- ミズホメディー
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 佐賀県鳥栖市藤木町５番地の４
- Postal code
- 8410048
- Prefecture
- 佐賀県
- Prefecture code
- 41
- City or district
- 鳥栖市
- City code
- 203
- Street address
- 藤木町５番地の４
- Organisation type
- 301
- Processing type
- 11
- Correction type
- 1
- Status
- Representative
- 代表取締役会長兼社長 唐川 文成
- Capital
- 464000000
- Employees
- 245
- Employees (male)
- Employees (female)
- Business summary
- Website URL
- Year founded
- Business category
- E:製造業
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2018-04-12
- Key information
- 2300001006311
§09
Sources & updates
DOMAINOwn domain：Yes
UPDATED2026-09-29 14:24 · Model: gpt-4.1-nano